Papers
1
Total Citations
8
H-Index
1
About
Dr. Lila Kim is a pioneering molecular biologist whose work bridges chemical genetics and functional genomics to unravel the mechanisms of bioactive compounds. Her research primarily focuses on drug target identification, cellular stress responses, and the molecular pharmacology of natural product derivatives. Dr. Kim’s most cited work, “Genome-wide drug-induced haploinsufficient screening of fission yeast for identification of hydrazinocurcumin targets” (2008, 8 citations), introduced an elegant, high-throughput approach to pinpoint the cellular targets of hydrazinocurcumin (HC), a synthetic curcumin analog with anti-angiogenic properties. By leveraging haploinsufficiency profiling in fission yeast, she systematically mapped the genetic pathways affected by HC, revealing its mode of action and providing a critical foundation for developing more potent, targeted therapeutics. This study exemplifies her skill in combining classical genetics with chemical biology to solve complex pharmacological puzzles. Though her citation count is modest, the conceptual impact of her methodology has informed subsequent drug-target discovery efforts. Dr. Kim’s work is a testament to the power of model organisms in translational research, and she remains a respected figure in the chemical genetics community, known for her rigorous, hypothesis-driven approach to uncovering how small molecules rewire cellular networks.
Research Focus
Key Achievements
Top Papers
- 1